QQ客服 官方微博 反馈留言

	Persistent donor derived V delta 4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI
	Xu, Ling[1]; Weng, Jianyu[2]; Huang, Xin[2]; Zeng, Chengwu[1]; Chen, Shaohua[1]; Geng, Suxia[2]; Yang, Lijian[1]; Wu, Suijing[2]; Huang, Suming[4]; Du, Xin[2]
刊名	ONCOTARGET
	2016
卷号	7页码:42943-42952
关键词	T-ALL T cell repertoire allo-HSCT MRD DLI Immunology and Microbiology Section Immune response Immunity
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2195541
专题	华南理工大学
作者单位	1.[1]Jinan Univ, Inst Hematol, Guangzhou, Guangdong, Peoples R China 2.[2]Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China 3.[3]Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou, Guangdong, Peoples R China 4.[4]Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA 5.[5]Jinan Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Xu, Ling[1],Weng, Jianyu[2],Huang, Xin[2],et al. Persistent donor derived V delta 4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI[J]. ONCOTARGET,2016,7:42943-42952.
APA	Xu, Ling[1].,Weng, Jianyu[2].,Huang, Xin[2].,Zeng, Chengwu[1].,Chen, Shaohua[1].,...&Li, Yangqiu[1,3,5].(2016).Persistent donor derived V delta 4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI.ONCOTARGET,7,42943-42952.
MLA	Xu, Ling[1],et al."Persistent donor derived V delta 4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI".ONCOTARGET 7(2016):42943-42952.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。